Search results for "" 2269 results found
Sort By
By Date
By Relevance
-
IP Cases & Articles
Borderline descriptive marks still enforceable
The EU General Court (GC) has upheld a finding of a likelihood of confusion between two figurative trade marks containing the descriptive words "EasyCredit" in relation to identical services. -
IP Cases & Articles
Fake goods online: blocking injunctions
The Court of Appeal has upheld the High Court's decision to grant orders requiring five internet service providers (ISPs) to block access to certain websites selling counterfeit goods. -
Newsletter
Trade Mark Newsletter No.88
-
IP Cases & Articles
US fast-tracks cancer immunology patent examinations
On 29 June 2016, the United States Patent and Trademark Office (USPTO) began a pilot program to provide for earlier review of patent applications pertaining to cancer immunotherapy (the"Cancer Immunotherapy Pilot Program"). -
IP Cases & Articles
IP & Brexit - UK & European patent law and practice
The UK has voted to leave the European Union. In this edition of our newsletter, we consider the impact of ‘Brexit’ on UK and European intellectual property law and practice. -
IP Cases & Articles
IP & Brexit - what has changed for design rights?
It is important to know that currently there is no change to EU intellectual property rights or laws. In particular, the scope, effectiveness and enforceability of unitary EU-wide designs remains the same, both within the UK and the other 27 member states. This will continue to be the case until… -
IP Cases & Articles
St. Regis v Park Regis: Sheraton v Staywell Hospitality
In this decision from the General Court, it was perhaps not surprising that the opposition by Sheraton (owner of the ST. REGIS brand) was successfully upheld by the General Court in respect of hotel services against the later filed application for PARK REGIS & Design. -
Webinars & Videos
European biotech patent case law
-
Newsletter
Patent Newsletter No.54
-
IP Cases & Articles
EPO fee refund rules for abandoned patent applications
When a European application is abandoned for commercial reasons, it is sometimes possible to obtain a refund of some of the European Patent Office (EPO) fees paid for the application.
Page 167 of 227
Previous Next